Correlation Between Codexis and AIM ImmunoTech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Codexis and AIM ImmunoTech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Codexis and AIM ImmunoTech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Codexis and AIM ImmunoTech, you can compare the effects of market volatilities on Codexis and AIM ImmunoTech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Codexis with a short position of AIM ImmunoTech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Codexis and AIM ImmunoTech.

Diversification Opportunities for Codexis and AIM ImmunoTech

0.85
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Codexis and AIM is 0.85. Overlapping area represents the amount of risk that can be diversified away by holding Codexis and AIM ImmunoTech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AIM ImmunoTech and Codexis is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Codexis are associated (or correlated) with AIM ImmunoTech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AIM ImmunoTech has no effect on the direction of Codexis i.e., Codexis and AIM ImmunoTech go up and down completely randomly.

Pair Corralation between Codexis and AIM ImmunoTech

Given the investment horizon of 90 days Codexis is expected to generate 1.0 times more return on investment than AIM ImmunoTech. However, Codexis is 1.0 times more volatile than AIM ImmunoTech. It trades about -0.16 of its potential returns per unit of risk. AIM ImmunoTech is currently generating about -0.2 per unit of risk. If you would invest  282.00  in Codexis on August 21, 2025 and sell it today you would lose (118.00) from holding Codexis or give up 41.84% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy98.44%
ValuesDaily Returns

Codexis  vs.  AIM ImmunoTech

 Performance 
       Timeline  
Codexis 

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Codexis has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in December 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
AIM ImmunoTech 

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days AIM ImmunoTech has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's forward indicators remain very healthy which may send shares a bit higher in December 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Codexis and AIM ImmunoTech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Codexis and AIM ImmunoTech

The main advantage of trading using opposite Codexis and AIM ImmunoTech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Codexis position performs unexpectedly, AIM ImmunoTech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AIM ImmunoTech will offset losses from the drop in AIM ImmunoTech's long position.
The idea behind Codexis and AIM ImmunoTech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.

Other Complementary Tools

Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing